Funding
Funding not disclosed
Founders
Product
Problem
Current methods for disease detection often rely on the manifestation of symptoms, leading to delayed diagnosis and intervention. Identifying disease signals at a molecular or thermodynamic level before clinical symptoms appear is a significant challenge in early disease detection.
Solution
Ofbrains offers a novel approach to disease detection by measuring the thermodynamic properties of biological fluids. This technology enables the identification of disease signals at their earliest stages, potentially before symptoms are clinically observable. By miniaturizing the process of clinical studies, Ofbrains facilitates rapid biomarker discovery, significantly reducing the time and resources required for research. The platform provides simple, fast, and non-invasive sensing techniques, making early disease detection more accessible and efficient.
Target Audience
The primary target audience includes researchers in academic institutions, pharmaceutical companies, and diagnostic laboratories focused on early disease detection and biomarker discovery.
Features
- Thermodynamic profiling of biological fluids for early disease signal detection.
- Miniaturized platform for rapid biomarker discovery, reducing study timelines from weeks to hours.
- Non-invasive sensing techniques for patient comfort and ease of use.
- Proprietary measurement methodologies focused on the physics and chemistry of biological fluids.
- Scalable to accommodate various cohort sizes for clinical studies.